CSPC Pharmaceutical Earlier Announced Strategic Research Collaboration, Option, License Agreement With AstraZeneca To Develop Novel Small Nu
CSPC Pharmaceutical Earlier Announced Strategic Research Collaboration, Option, License Agreement With AstraZeneca To Develop Novel Small Nucleic Acid Drug Candidates Using Proprietary SiRNA Drug Discovery And Extrahepatic Targeted Delivery Platforms
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.